Can Ansay has drawn attention in Europe as a tech-focused founder who wants patients to have faster access to sick notes and similar services from home. His company, DrAnsay, connects users with licensed professionals who can review cases remotely, which reflects a broader move toward greater medical freedom under clear rules.
Ansay trained as a lawyer before turning to health technology, and public profiles describe how his interest in patient empowerment grew during the COVID-19 pandemic, when many people struggled to reach clinics for basic documentation. He saw that many workers needed a simple way to obtain certificates without long travel or waiting times, and that insight led him to support digital solutions that could serve large groups while still respecting national laws. This background helps explain why DrAnsay focuses so strongly on convenience, legal compliance, and clarity for patients and employers.
The company’s model centers on web-based sick notes and related services that people can request from home, rather than relying on traditional in-person visits for every minor illness. That structure has been reported in several European markets, where DrAnsay partners with licensed professionals who review patient information and decide whether a certificate is appropriate.
Observers say the platform has seen high usage in countries such as Germany and France, suggesting growing demand for remote services that align with work routines and modern expectations of flexibility.
Growth for DrAnsay has come with regulatory and public scrutiny, which is common for health startups that alter familiar routines. Professional bodies and regulators in some countries have questioned whether remote certificates might strain existing systems if oversight weakens, while supporters argue that such services can reduce unnecessary clinic visits and free time for more complex cases.
The debate around DrAnsay therefore tracks the wider health startup revolution: new platforms seek to empower patients and reshape access, while governments and regulators adjust rules to balance innovation, safety, and fair use of public resources.
About DrAnsay
DrAnsay is a European health technology company that provides remote access to medical certificates and related services within the growing digital health economy. The company has expanded from Germany into several international markets, positioning its platform at the center of ongoing policy debates about telehealth, cross-border access, and regulatory oversight in modern healthcare systems.
Contact Information
Contact Person: Jeanette Hepp
Company: DrAnsay Ltd.
Company Website: https://dransay.com/
Email Address: [email protected]
Location: Valletta, Malta
